CANDESARTAN CILEXETIL

CANDESARTAN CILEXETIL was reported 26482 times

CANDESARTAN CILEXETIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 26 0.8667
1 NEUROLOGIC NEGLECT SYNDROME 160 0.2878
2 CARDIOSPASM 160 0.2867
3 VENA CAVA INJURY 25 0.2717
4 PULMONARY VASCULITIS 129 0.2398
5 IMMUNISATION 103 0.2373
6 PALMOPLANTAR KERATODERMA 157 0.2166
7 CAROTID ARTERY THROMBOSIS 165 0.1943
8 TOTAL LUNG CAPACITY ABNORMAL 74 0.1902
9 RENAL CYST HAEMORRHAGE 37 0.1637
10 CAPILLARITIS 45 0.1630
11 ADJUSTMENT DISORDER 164 0.1262
12 SPIROMETRY ABNORMAL 74 0.1237
13 MITE ALLERGY 70 0.1069
14 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 25 0.0825
15 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 60 0.0819
16 NEURITIS 125 0.0809
17 MYCOTIC ALLERGY 69 0.0807
18 VASCULAR COMPRESSION 25 0.0791
19 BLOOD GROWTH HORMONE INCREASED 43 0.0771
20 ATRIAL TACHYCARDIA 161 0.0766
21 DUST ALLERGY 73 0.0744
22 PRURITUS GENITAL 166 0.0704
23 PERSONALITY DISORDER 167 0.0637
24 CATARRH 53 0.0586
25 OVERLAP SYNDROME 40 0.0571
26 STEROID DEPENDENCE 49 0.0558
27 CONJUNCTIVITIS ALLERGIC 76 0.0513
28 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 47 0.0507
29 CAROTID ARTERY OCCLUSION 183 0.0501
30 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 102 0.0500
31 RESPIRATORY SYMPTOM 129 0.0453
32 DELAYED GRAFT FUNCTION 32 0.0450
33 FORCED EXPIRATORY VOLUME DECREASED 120 0.0423
34 RENAL ARTERY STENOSIS 58 0.0421
35 CAROTID ARTERIOSCLEROSIS 40 0.0388
36 TENSION HEADACHE 164 0.0381
37 SLEEP TERROR 158 0.0375
38 ARTERIAL OCCLUSIVE DISEASE 286 0.0363
39 INTERVERTEBRAL DISC SPACE NARROWING 28 0.0347
40 GANGRENE 207 0.0343
41 AORTIC DILATATION 37 0.0333
42 BURNS SECOND DEGREE 56 0.0319
43 PULMONARY HYPOPLASIA 25 0.0317
44 NORMOCHROMIC NORMOCYTIC ANAEMIA 91 0.0303
45 INSULIN-LIKE GROWTH FACTOR INCREASED 43 0.0301
46 VASCULITIS 350 0.0300
47 RUBBER SENSITIVITY 45 0.0294
48 SUPERFICIAL VEIN THROMBOSIS 23 0.0273
49 RECTAL PROLAPSE 32 0.0265
50 TOTAL LUNG CAPACITY DECREASED 42 0.0263
51 BLOOD PRESSURE INADEQUATELY CONTROLLED 154 0.0256
52 AORTIC ARTERIOSCLEROSIS 62 0.0241
53 PULMONARY ALVEOLAR HAEMORRHAGE 132 0.0235
54 HEMIPLEGIA 194 0.0233
55 SENSORY LOSS 186 0.0231
56 VASCULAR PURPURA 32 0.0229
57 CHOLESTATIC LIVER INJURY 50 0.0224
58 LUPUS VULGARIS 28 0.0222
59 OLIGOHYDRAMNIOS 74 0.0222
60 BLEPHAROSPASM 139 0.0221
61 NEUROLOGICAL SYMPTOM 126 0.0220
62 SUBARACHNOID HAEMORRHAGE 223 0.0219
63 FACET JOINT SYNDROME 71 0.0218
64 FACIAL PAIN 181 0.0203
65 ARTERIOSCLEROSIS CORONARY ARTERY 134 0.0202
66 PNEUMOCYSTIS JIROVECII INFECTION 24 0.0201
67 DEEP VEIN THROMBOSIS POSTOPERATIVE 40 0.0200
68 HYPERPARATHYROIDISM SECONDARY 50 0.0199
69 OBSTRUCTIVE SLEEP APNOEA SYNDROME 28 0.0192
70 ALCOHOL POISONING 51 0.0190
71 OBSTRUCTIVE AIRWAYS DISORDER 205 0.0184
72 ALVEOLITIS 26 0.0184
73 MOTOR DYSFUNCTION 187 0.0183
74 BRONCHIECTASIS 123 0.0182
75 ACTINIC KERATOSIS 47 0.0181
76 AORTIC VALVE INCOMPETENCE 77 0.0181
77 DIVERTICULUM INTESTINAL 78 0.0178
78 LUNG OPACITY 46 0.0174
79 AFFECT LABILITY 167 0.0173
80 ARTERIOSCLEROSIS 160 0.0170
81 HYPOPNOEA 58 0.0167
82 SPUTUM DISCOLOURED 151 0.0159
83 LEFT VENTRICULAR HYPERTROPHY 68 0.0159
84 PERICARDITIS 265 0.0158
85 SINUS CONGESTION 210 0.0155
86 RHEUMATIC FEVER 69 0.0155
87 PRODUCT MONITORING ERROR 22 0.0152
88 HEPATOSPLENOMEGALY 39 0.0152
89 PERIPHERAL VENOUS DISEASE 62 0.0152
90 MUSCLE SPASTICITY 184 0.0150
91 FINGER DEFORMITY 72 0.0148
92 COMPLICATIONS OF TRANSPLANTED KIDNEY 33 0.0145
93 HYPERKALAEMIA 510 0.0145
94 HYPOTHALAMO-PITUITARY DISORDER 21 0.0144
95 SUBILEUS 30 0.0144
96 POLYP 94 0.0143
97 WOUND INFECTION 155 0.0141
98 CEREBRAL HAEMATOMA 47 0.0140
99 VENOUS OCCLUSION 25 0.0137
100 MEAN CELL VOLUME INCREASED 35 0.0136
101 ATRIOVENTRICULAR BLOCK FIRST DEGREE 59 0.0136
102 DISLOCATION OF VERTEBRA 31 0.0136
103 ANGINA PECTORIS 389 0.0136
104 VENTRICULAR TACHYCARDIA 223 0.0135
105 PULMONARY FIBROSIS 258 0.0134
106 HYPERURICAEMIA 53 0.0129
107 X-RAY ABNORMAL 23 0.0128
108 COORDINATION ABNORMAL 177 0.0127
109 SKIN HAEMORRHAGE 188 0.0127
110 HYPERPARATHYROIDISM 26 0.0126
111 HYPERCHOLESTEROLAEMIA 121 0.0125
112 POTENTIATING DRUG INTERACTION 42 0.0125
113 ONYCHOMADESIS 52 0.0124
114 BURSITIS 150 0.0124
115 INJECTION SITE OEDEMA 21 0.0122
116 FOLLICULITIS 128 0.0122
117 THERAPEUTIC AGENT TOXICITY 40 0.0120
118 HEMIPARESIS 203 0.0120
119 ANOSMIA 171 0.0118
120 RENAL TUBULAR DISORDER 33 0.0117
121 RALES 68 0.0117
122 CARDIAC MURMUR 100 0.0115
123 BENIGN PROSTATIC HYPERPLASIA 59 0.0114
124 DYSPNOEA AT REST 33 0.0114
125 RESPIRATORY TRACT CONGESTION 177 0.0111
126 FULL BLOOD COUNT ABNORMAL 117 0.0111
127 GRIP STRENGTH DECREASED 97 0.0110
128 PRODUCT LABEL CONFUSION 64 0.0110
129 RENAL FAILURE ACUTE 463 0.0109
130 TACHYARRHYTHMIA 27 0.0108
131 ORTHOSTATIC HYPOTENSION 188 0.0108
132 SINUS DISORDER 213 0.0107
133 HYPOVENTILATION 35 0.0107
134 MIXED LIVER INJURY 32 0.0106
135 INGROWING NAIL 25 0.0106
136 BACK INJURY 115 0.0106
137 TENOSYNOVITIS 29 0.0105
138 DUODENAL ULCER PERFORATION 78 0.0105
139 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 53 0.0105
140 SENSITIVITY TO WEATHER CHANGE 54 0.0103
141 RENAL CYST 81 0.0102
142 GASTRIC POLYPS 23 0.0102
143 PLEURITIC PAIN 28 0.0101
144 SPINAL OSTEOARTHRITIS 88 0.0100
145 BUNDLE BRANCH BLOCK LEFT 42 0.0099
146 RENAL FAILURE CHRONIC 75 0.0097
147 SWOLLEN JOINT COUNT INCREASED 31 0.0097
148 NAIL DISORDER 85 0.0097
149 BLOOD PRESSURE SYSTOLIC ABNORMAL 24 0.0097
150 HYPERLACTACIDAEMIA 26 0.0097
151 LICHEN PLANUS 22 0.0095
152 DIASTOLIC DYSFUNCTION 29 0.0094
153 LARGE INTESTINE POLYP 65 0.0094
154 ONYCHOMYCOSIS 41 0.0093
155 CHRONIC GASTRITIS 21 0.0093
156 CYSTITIS 288 0.0090
157 INFUSION SITE REACTION 27 0.0090
158 CYTOLYTIC HEPATITIS 30 0.0090
159 MITRAL VALVE INCOMPETENCE 102 0.0090
160 BREAST CANCER STAGE III 58 0.0089
161 EATING DISORDER 189 0.0089
162 RHINITIS 71 0.0088
163 BLOOD PRESSURE FLUCTUATION 210 0.0087
164 SNEEZING 196 0.0087
165 C-REACTIVE PROTEIN ABNORMAL 56 0.0087
166 TROPONIN INCREASED 66 0.0087
167 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 147 0.0086
168 HYPERTENSIVE CRISIS 96 0.0086
169 COMA SCALE ABNORMAL 25 0.0086
170 TRANSIENT ISCHAEMIC ATTACK 291 0.0086
171 CORONARY ARTERY OCCLUSION 117 0.0085
172 TRICUSPID VALVE INCOMPETENCE 67 0.0084
173 ACUTE PULMONARY OEDEMA 47 0.0084
174 PAROSMIA 63 0.0083
175 VITAMIN B12 DECREASED 24 0.0083
176 HYPONATRAEMIA 466 0.0083
177 HAEMOPTYSIS 230 0.0082
178 SPINAL STENOSIS 34 0.0082
179 BRADYCARDIA 436 0.0082
180 NEPHROGENIC ANAEMIA 38 0.0082
181 VENTRICULAR EXTRASYSTOLES 85 0.0082
182 APHASIA 245 0.0081
183 CORONARY ARTERY STENOSIS 40 0.0079
184 MUSCLE TWITCHING 182 0.0079
185 DIPLOPIA 205 0.0079
186 GASTROINTESTINAL NECROSIS 23 0.0079
187 COELIAC DISEASE 77 0.0078
188 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 56 0.0078
189 BLOOD CHOLESTEROL ABNORMAL 36 0.0078
190 BLOOD PRESSURE SYSTOLIC INCREASED 151 0.0077
191 SUPRAVENTRICULAR EXTRASYSTOLES 26 0.0077
192 GINGIVAL PAIN 61 0.0077
193 HYPOTHYROIDISM 243 0.0076
194 BLOOD PRESSURE INCREASED 1156 0.0076
195 PEPTIC ULCER 25 0.0075
196 HEPATIC STEATOSIS 140 0.0075
197 ATRIOVENTRICULAR BLOCK 58 0.0075
198 ISCHAEMIC CARDIOMYOPATHY 23 0.0075
199 ANXIETY DISORDER 25 0.0075
200 PEMPHIGOID 56 0.0074
201 SHOCK HAEMORRHAGIC 60 0.0074
202 HYPOVOLAEMIA 43 0.0073
203 DUODENAL ULCER HAEMORRHAGE 21 0.0073
204 BLOOD PRESSURE DIASTOLIC DECREASED 54 0.0073
205 BLOOD CALCIUM INCREASED 64 0.0073
206 BLOOD UREA INCREASED 122 0.0073
207 LEFT VENTRICULAR FAILURE 25 0.0073
208 NODULE 94 0.0072
209 BUNDLE BRANCH BLOCK RIGHT 33 0.0072
210 TOXIC SKIN ERUPTION 72 0.0071
211 SQUAMOUS CELL CARCINOMA OF SKIN 43 0.0071
212 GOITRE 29 0.0071
213 TINNITUS 325 0.0071
214 BONE EROSION 25 0.0071
215 ANGIOEDEMA 312 0.0070
216 SNORING 26 0.0069
217 HEPATITIS ACUTE 44 0.0068
218 PAIN OF SKIN 182 0.0068
219 ANURIA 58 0.0067
220 RASH PAPULAR 151 0.0067
221 WHEEZING 398 0.0067
222 CARDIOMEGALY 82 0.0067
223 BLOOD POTASSIUM INCREASED 108 0.0066
224 LIVER FUNCTION TEST INCREASED 142 0.0066
225 PRODUCTIVE COUGH 315 0.0066
226 GAMMA-GLUTAMYLTRANSFERASE INCREASED 145 0.0065
227 TUBULOINTERSTITIAL NEPHRITIS 122 0.0065
228 ANGINA UNSTABLE 42 0.0065
229 C-REACTIVE PROTEIN INCREASED 234 0.0064
230 BLOOD URIC ACID INCREASED 37 0.0064
231 DYSARTHRIA 241 0.0064
232 PEMPHIGUS 80 0.0064
233 BLOOD CREATININE INCREASED 412 0.0063
234 HIGH DENSITY LIPOPROTEIN DECREASED 21 0.0063
235 CATARACT 375 0.0063
236 EPILEPSY 192 0.0063
237 MUSCLE INJURY 52 0.0063
238 HYPOVOLAEMIC SHOCK 30 0.0063
239 GASTRITIS EROSIVE 29 0.0062
240 EYE PRURITUS 208 0.0062
241 LIP SWELLING 205 0.0061
242 BASAL CELL CARCINOMA 96 0.0061
243 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 63 0.0061
244 HELICOBACTER INFECTION 63 0.0061
245 ACUTE KIDNEY INJURY 933 0.0061
246 LIVE BIRTH 51 0.0061
247 ISCHAEMIA 28 0.0061
248 HYPERTHYROIDISM 88 0.0061
249 RHEUMATOID FACTOR POSITIVE 35 0.0061
250 ADVERSE REACTION 80 0.0060
251 ASPIRATION 66 0.0060
252 EXOSTOSIS 55 0.0060
253 MUSCULAR WEAKNESS 684 0.0060
254 LUNG DISORDER 294 0.0060
255 CREATININE RENAL CLEARANCE DECREASED 24 0.0060
256 PALPITATIONS 701 0.0060
257 ATRIOVENTRICULAR BLOCK COMPLETE 40 0.0060
258 SCOLIOSIS 37 0.0060
259 HYPERLIPIDAEMIA 71 0.0059
260 INGUINAL HERNIA 36 0.0059
261 GASTROOESOPHAGEAL REFLUX DISEASE 476 0.0059
262 ESCHERICHIA URINARY TRACT INFECTION 25 0.0059
263 HIATUS HERNIA 76 0.0059
264 TASTE DISORDER 119 0.0059
265 IRON DEFICIENCY ANAEMIA 54 0.0058
266 BLOOD PRESSURE DIASTOLIC INCREASED 27 0.0058
267 HAEMORRHOIDS 114 0.0058
268 IRON DEFICIENCY 26 0.0058
269 GLOMERULAR FILTRATION RATE DECREASED 71 0.0058
270 CEREBRAL ATROPHY 23 0.0058
271 SWELLING OF EYELID 36 0.0057
272 LIP DRY 52 0.0057
273 MIGRAINE 546 0.0057
274 BODY TEMPERATURE DECREASED 56 0.0057
275 MYOSITIS 51 0.0057
276 ISCHAEMIC STROKE 101 0.0057
277 DIVERTICULUM 40 0.0056
278 VARICOSE VEIN 29 0.0056
279 ERYSIPELAS 28 0.0056
280 HEPATOCELLULAR INJURY 79 0.0056
281 ARTHRITIS 436 0.0055
282 DIABETES MELLITUS INADEQUATE CONTROL 98 0.0055
283 DUODENAL ULCER 39 0.0055
284 ADRENAL INSUFFICIENCY 67 0.0055
285 CONGESTIVE CARDIOMYOPATHY 23 0.0055
286 HYPERTENSION 1160 0.0055
287 GOUT 98 0.0055
288 CEREBRAL ISCHAEMIA 28 0.0054
289 CHOLESTASIS 104 0.0054
290 HEPATIC CYTOLYSIS 69 0.0054
291 HEART RATE DECREASED 190 0.0054
292 INFARCTION 37 0.0054
293 RENAL TUBULAR NECROSIS 53 0.0054
294 CONTRAINDICATED PRODUCT ADMINISTERED 162 0.0053
295 RED BLOOD CELL SEDIMENTATION RATE INCREASED 59 0.0053
296 HAEMORRHOIDAL HAEMORRHAGE 26 0.0053
297 OEDEMA PERIPHERAL 649 0.0053
298 MELAENA 117 0.0053
299 LUPUS-LIKE SYNDROME 48 0.0053
300 HAEMOLYTIC ANAEMIA 47 0.0052
301 HEPATITIS 134 0.0052
302 METABOLIC ACIDOSIS 167 0.0052
303 VERTIGO 318 0.0052
304 TRANSAMINASES INCREASED 116 0.0052
305 PROTEIN URINE PRESENT 26 0.0052
306 BLOOD SODIUM DECREASED 98 0.0052
307 PURPURA 46 0.0052
308 CORONARY ARTERY DISEASE 157 0.0052
309 HYPOMAGNESAEMIA 72 0.0052
310 CARDIAC FAILURE CHRONIC 22 0.0052
311 BLINDNESS 210 0.0051
312 DYSLIPIDAEMIA 26 0.0051
313 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 245 0.0051
314 MULTI-ORGAN FAILURE 88 0.0051
315 DRUG INTERACTION 800 0.0050
316 DISTURBANCE IN ATTENTION 271 0.0050
317 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 39 0.0050
318 HYPOCALCAEMIA 95 0.0050
319 INTERNATIONAL NORMALISED RATIO INCREASED 143 0.0050
320 HAEMORRHAGIC ANAEMIA 22 0.0050
321 HAEMORRHAGIC STROKE 39 0.0050
322 LACTIC ACIDOSIS 160 0.0049
323 SYNOVITIS 89 0.0049
324 HYPERKERATOSIS 27 0.0049
325 PHLEBITIS 25 0.0049
326 CARDIAC FAILURE 391 0.0049
327 RHABDOMYOLYSIS 203 0.0049
328 OSTEOARTHRITIS 206 0.0049
329 ORGANISING PNEUMONIA 24 0.0048
330 HEART RATE ABNORMAL 27 0.0048
331 BLOOD PRESSURE SYSTOLIC DECREASED 22 0.0048
332 HYPOKALAEMIA 223 0.0048
333 HEPATITIS CHOLESTATIC 29 0.0048
334 EOSINOPHILIA 84 0.0048
335 ATRIAL FIBRILLATION 466 0.0048
336 HYPOTENSION 958 0.0048
337 LYMPHOEDEMA 33 0.0048
338 POLYNEUROPATHY 57 0.0048
339 COGNITIVE DISORDER 221 0.0047
340 RHINORRHOEA 305 0.0047
341 OBESITY 75 0.0047
342 LIPASE INCREASED 36 0.0047
343 PANCREATITIS ACUTE 105 0.0047
344 HAEMATOMA 121 0.0047
345 BREATH SOUNDS ABNORMAL 23 0.0047
346 IRRITABLE BOWEL SYNDROME 100 0.0047
347 GINGIVITIS 25 0.0046
348 INTERSTITIAL LUNG DISEASE 224 0.0046
349 TENDON RUPTURE 57 0.0046
350 TYPE 2 DIABETES MELLITUS 155 0.0046
351 HAND DEFORMITY 60 0.0046
352 JAUNDICE 123 0.0046
353 JOINT RANGE OF MOTION DECREASED 61 0.0045
354 GASTRIC ULCER HAEMORRHAGE 25 0.0045
355 SYSTEMIC LUPUS ERYTHEMATOSUS 160 0.0045
356 BLOOD CREATINE PHOSPHOKINASE INCREASED 129 0.0045
357 PERIPHERAL VASCULAR DISORDER 23 0.0045
358 TENDON DISORDER 29 0.0044
359 VITAMIN D DECREASED 38 0.0044
360 ASTHMA 502 0.0044
361 ARRHYTHMIA 210 0.0044
362 HYPOXIA 156 0.0044
363 BLOOD PRESSURE ABNORMAL 88 0.0044
364 HYPOGLYCAEMIA 214 0.0044
365 CONFUSIONAL STATE 712 0.0044
366 EJECTION FRACTION DECREASED 68 0.0044
367 AMNESIA 284 0.0044
368 SUDDEN DEATH 46 0.0043
369 ACUTE CORONARY SYNDROME 36 0.0043
370 ACUTE MYOCARDIAL INFARCTION 128 0.0043
371 ENTEROCOLITIS 25 0.0043
372 DYSPNOEA EXERTIONAL 162 0.0043
373 TACHYCARDIA 381 0.0043
374 RENAL IMPAIRMENT 360 0.0043
375 CONGENITAL ANOMALY 33 0.0043
376 AGRANULOCYTOSIS 79 0.0042
377 PULMONARY CONGESTION 56 0.0042
378 URINE OUTPUT DECREASED 37 0.0042
379 RED BLOOD CELL COUNT DECREASED 121 0.0042
380 GASTRITIS 111 0.0042
381 CEREBRAL INFARCTION 103 0.0042
382 PLEURISY 25 0.0042
383 TENDONITIS 65 0.0042
384 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37 0.0042
385 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
386 INTENTIONAL PRODUCT USE ISSUE 366 0.0042
387 CIRCULATORY COLLAPSE 71 0.0042
388 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 27 0.0042
389 ULCER 66 0.0041
390 FEMORAL NECK FRACTURE 21 0.0041
391 GASTROINTESTINAL DISORDER 366 0.0041
392 CORONAVIRUS INFECTION 27 0.0041
393 BRONCHOSPASM 58 0.0041
394 DRUG ERUPTION 72 0.0041
395 RECTAL HAEMORRHAGE 174 0.0040
396 HAEMODIALYSIS 34 0.0040
397 CHEST DISCOMFORT 414 0.0040
398 PYELONEPHRITIS 35 0.0040
399 IMPAIRED QUALITY OF LIFE 58 0.0040
400 ELECTROCARDIOGRAM QT PROLONGED 145 0.0040
401 ESCHERICHIA INFECTION 33 0.0040
402 EXTRASYSTOLES 28 0.0040
403 PROTEINURIA 76 0.0040
404 HYPOKINESIA 58 0.0040
405 SYNCOPE 399 0.0040
406 BLOOD ALKALINE PHOSPHATASE INCREASED 99 0.0040
407 PULMONARY HYPERTENSION 83 0.0040
408 URINARY INCONTINENCE 118 0.0040
409 SUBDURAL HAEMATOMA 57 0.0040
410 PLEURAL EFFUSION 241 0.0040
411 RESTLESS LEGS SYNDROME 72 0.0040
412 PRESYNCOPE 96 0.0039
413 BLOOD CHOLESTEROL INCREASED 184 0.0039
414 DEHYDRATION 525 0.0039
415 PERIPHERAL COLDNESS 54 0.0039
416 SINUS BRADYCARDIA 38 0.0039
417 GAIT INABILITY 131 0.0039
418 BLOOD TEST ABNORMAL 55 0.0039
419 BLOOD ALBUMIN DECREASED 31 0.0039
420 SEROTONIN SYNDROME 75 0.0039
421 FALL 1296 0.0039
422 BLOOD PRESSURE DECREASED 258 0.0039
423 RESPIRATORY DISORDER 116 0.0039
424 RHEUMATOID ARTHRITIS 440 0.0039
425 RASH MACULO-PAPULAR 86 0.0039
426 RENAL FAILURE 513 0.0039
427 HEART RATE IRREGULAR 87 0.0038
428 HEART RATE INCREASED 379 0.0038
429 ELECTROCARDIOGRAM ABNORMAL 30 0.0038
430 SINUSITIS 391 0.0038
431 POLYURIA 31 0.0038
432 HAEMATOCRIT DECREASED 75 0.0038
433 LOWER LIMB FRACTURE 72 0.0037
434 HEPATIC CIRRHOSIS 70 0.0037
435 ANOREXIA 48 0.0037
436 GLUCOSE TOLERANCE IMPAIRED 22 0.0037
437 NEUTROPHIL COUNT INCREASED 38 0.0037
438 RASH PUSTULAR 27 0.0037
439 OLIGURIA 23 0.0037
440 SCIATICA 59 0.0037
441 ULCER HAEMORRHAGE 25 0.0037
442 WOUND 103 0.0037
443 CARDIAC VALVE DISEASE 21 0.0037
444 GENERAL PHYSICAL HEALTH DETERIORATION 423 0.0037
445 EXERCISE TOLERANCE DECREASED 21 0.0036
446 PULMONARY EMBOLISM 344 0.0036
447 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 62 0.0036
448 LOWER RESPIRATORY TRACT INFECTION 163 0.0036
449 DRUG INTOLERANCE 346 0.0036
450 NECK PAIN 200 0.0036
451 GLOSSODYNIA 80 0.0036
452 GLYCOSYLATED HAEMOGLOBIN INCREASED 90 0.0036
453 BLOOD IRON DECREASED 42 0.0035
454 HEPATIC FUNCTION ABNORMAL 131 0.0035
455 PHOTOPHOBIA 66 0.0035
456 HEARING IMPAIRED 21 0.0035
457 ECCHYMOSIS 24 0.0035
458 CHEST PAIN 648 0.0035
459 FACE OEDEMA 59 0.0035
460 ANAEMIA 666 0.0035
461 SWOLLEN TONGUE 109 0.0035
462 CONCUSSION 27 0.0035
463 SECOND PRIMARY MALIGNANCY 29 0.0035
464 HAEMOGLOBIN DECREASED 358 0.0035
465 HYPERCALCAEMIA 43 0.0035
466 SHOCK 80 0.0035
467 BLOOD THYROID STIMULATING HORMONE INCREASED 32 0.0035
468 MUSCULOSKELETAL PAIN 182 0.0035
469 GASTRIC ULCER 66 0.0035
470 MEMORY IMPAIRMENT 477 0.0035
471 LARGE INTESTINE PERFORATION 24 0.0035
472 FIBROMYALGIA 84 0.0035
473 ATAXIA 41 0.0035
474 PETECHIAE 36 0.0034
475 FREQUENT BOWEL MOVEMENTS 93 0.0034
476 TORSADE DE POINTES 27 0.0034
477 ENTERITIS 22 0.0034
478 INFLAMMATION 176 0.0034
479 NIGHTMARE 118 0.0034
480 ECZEMA 178 0.0034
481 END STAGE RENAL DISEASE 62 0.0034
482 COUGH 953 0.0034
483 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 240 0.0034
484 DELIRIUM 117 0.0034
485 BODY HEIGHT DECREASED 36 0.0034
486 GASTROENTERITIS 49 0.0034
487 URINARY RETENTION 112 0.0034
488 CARDIOGENIC SHOCK 48 0.0033
489 BLOOD LACTATE DEHYDROGENASE INCREASED 53 0.0033
490 MUSCLE DISORDER 27 0.0033
491 SLUGGISHNESS 34 0.0033
492 DERMATITIS BULLOUS 24 0.0033
493 DYSPEPSIA 326 0.0033
494 NEPHROPATHY TOXIC 37 0.0033
495 BONE DISORDER 60 0.0033
496 PARKINSONISM 32 0.0033
497 HYPERHIDROSIS 422 0.0033
498 EMPHYSEMA 33 0.0033
499 CEREBROVASCULAR ACCIDENT 553 0.0033
500 ATRIAL FLUTTER 26 0.0033
501 HEAD INJURY 103 0.0033
502 UROSEPSIS 30 0.0032
503 MYOCARDIAL ISCHAEMIA 37 0.0032
504 SLEEP APNOEA SYNDROME 62 0.0032
505 HAND FRACTURE 23 0.0032
506 MYOCARDIAL INFARCTION 566 0.0032
507 DIABETES MELLITUS 247 0.0032
508 MIOSIS 26 0.0032
509 DYSPHAGIA 307 0.0032
510 RETINAL HAEMORRHAGE 23 0.0032
511 IMPAIRED WORK ABILITY 69 0.0032
512 BLOOD TRIGLYCERIDES INCREASED 57 0.0032
513 LIVER DISORDER 143 0.0032
514 SKIN EXFOLIATION 272 0.0032
515 HYPOALBUMINAEMIA 25 0.0032
516 NOCTURIA 39 0.0032
517 NEPHROTIC SYNDROME 22 0.0032
518 HAEMATOCHEZIA 177 0.0032
519 QUALITY OF LIFE DECREASED 43 0.0032
520 CHOLELITHIASIS 105 0.0032
521 BLOOD CALCIUM DECREASED 36 0.0032
522 HALLUCINATION 241 0.0032
523 THERAPEUTIC PRODUCT EFFECT DECREASED 143 0.0032
524 CARDIOMYOPATHY 47 0.0032
525 ALANINE AMINOTRANSFERASE INCREASED 195 0.0032
526 GLAUCOMA 61 0.0032
527 MALAISE 1380 0.0031
528 IMPAIRED HEALING 103 0.0031
529 OEDEMA 170 0.0031
530 INTERVERTEBRAL DISC DEGENERATION 29 0.0031
531 ABDOMINAL PAIN UPPER 643 0.0031
532 HYPOPHOSPHATAEMIA 23 0.0031
533 SEPTIC SHOCK 135 0.0031
534 HYPERGLYCAEMIA 113 0.0031
535 CHROMATURIA 70 0.0031
536 MACULAR DEGENERATION 37 0.0031
537 DYSPNOEA 1752 0.0031
538 PULMONARY MASS 46 0.0031
539 PYREXIA 1066 0.0031
540 SQUAMOUS CELL CARCINOMA 29 0.0031
541 PANCYTOPENIA 172 0.0031
542 LUNG INFILTRATION 27 0.0031
543 ACUTE RESPIRATORY DISTRESS SYNDROME 54 0.0031
544 MYALGIA 518 0.0030
545 DIZZINESS 1519 0.0030
546 MUSCULOSKELETAL STIFFNESS 266 0.0030
547 GASTRIC DISORDER 104 0.0030
548 PNEUMONIA 978 0.0030
549 AUTOIMMUNE HEPATITIS 21 0.0030
550 DYSURIA 111 0.0030
551 ELECTROLYTE IMBALANCE 35 0.0030
552 HAEMATURIA 103 0.0030
553 ACCIDENTAL OVERDOSE 110 0.0030
554 WRIST FRACTURE 36 0.0030
555 MICTURITION URGENCY 34 0.0030
556 SLEEP DISORDER 210 0.0030
557 ASPARTATE AMINOTRANSFERASE INCREASED 158 0.0030
558 UPPER GASTROINTESTINAL HAEMORRHAGE 50 0.0030
559 DRY MOUTH 241 0.0030
560 ANXIETY 845 0.0030
561 INTENTIONAL DRUG MISUSE 62 0.0030
562 ASCITES 87 0.0030
563 BRONCHITIS 219 0.0030
564 SINUS TACHYCARDIA 42 0.0030
565 EYE INFLAMMATION 28 0.0029
566 EAR PAIN 57 0.0029
567 ASTHENIA 1096 0.0029
568 THIRST 52 0.0029
569 LIMB DISCOMFORT 90 0.0029
570 GENERALISED OEDEMA 36 0.0029
571 BONE MARROW FAILURE 59 0.0029
572 SPINAL COMPRESSION FRACTURE 24 0.0029
573 BLOOD COUNT ABNORMAL 44 0.0029
574 DEPRESSED LEVEL OF CONSCIOUSNESS 114 0.0029
575 JOINT SWELLING 347 0.0029
576 PULMONARY OEDEMA 128 0.0029
577 GINGIVAL BLEEDING 39 0.0029
578 CHOLECYSTITIS 34 0.0029
579 INFLUENZA 318 0.0028
580 ABDOMINAL DISCOMFORT 478 0.0028
581 HEPATOMEGALY 28 0.0028
582 PERIPHERAL SWELLING 438 0.0028
583 MUSCLE RIGIDITY 34 0.0028
584 INFLUENZA LIKE ILLNESS 234 0.0028
585 LOW DENSITY LIPOPROTEIN INCREASED 22 0.0028
586 STOMATITIS 172 0.0028
587 DISORIENTATION 112 0.0028
588 FEELING DRUNK 21 0.0028
589 HYPOAESTHESIA 423 0.0028
590 SKIN ULCER 73 0.0028
591 CELLULITIS 142 0.0028
592 ALTERED STATE OF CONSCIOUSNESS 61 0.0028
593 LACRIMATION INCREASED 85 0.0028
594 FOOT DEFORMITY 31 0.0028
595 PHARYNGEAL OEDEMA 43 0.0028
596 MYOCARDITIS 32 0.0028
597 BLOOD URINE PRESENT 53 0.0028
598 VENTRICULAR FIBRILLATION 31 0.0028
599 PARAESTHESIA 439 0.0028
600 ABDOMINAL DISTENSION 291 0.0028
601 DIVERTICULITIS 77 0.0028
602 MYOPATHY 24 0.0028
603 PAIN IN EXTREMITY 818 0.0028
604 ARTHROPATHY 154 0.0028
605 AUTOIMMUNE DISORDER 27 0.0028
606 INSOMNIA 735 0.0028
607 DRY THROAT 28 0.0028
608 MEDICATION ERROR 153 0.0027
609 NASOPHARYNGITIS 506 0.0027
610 INTENTIONAL PRODUCT MISUSE 240 0.0027
611 SKIN LESION 75 0.0027
612 OSTEOPOROSIS 112 0.0027
613 LOSS OF CONSCIOUSNESS 348 0.0027
614 POLLAKIURIA 113 0.0027
615 POST PROCEDURAL INFECTION 22 0.0027
616 VISUAL IMPAIRMENT 334 0.0027
617 ATELECTASIS 26 0.0027
618 CEREBRAL HAEMORRHAGE 96 0.0027
619 DIZZINESS POSTURAL 26 0.0027
620 RIB FRACTURE 55 0.0027
621 APATHY 39 0.0027
622 BACK PAIN 620 0.0027
623 POST PROCEDURAL HAEMORRHAGE 31 0.0027
624 PSORIATIC ARTHROPATHY 108 0.0027
625 HEPATIC FAILURE 80 0.0027
626 CARDIAC FAILURE CONGESTIVE 213 0.0026
627 INJURY 186 0.0026
628 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
629 CHOLECYSTECTOMY 30 0.0026
630 EYE HAEMORRHAGE 35 0.0026
631 GROIN PAIN 23 0.0026
632 METASTASES TO LIVER 46 0.0026
633 HEADACHE 1637 0.0026
634 HYPERBILIRUBINAEMIA 27 0.0026
635 ANAPHYLACTIC SHOCK 67 0.0026
636 PNEUMOCYSTIS JIROVECII PNEUMONIA 26 0.0026
637 MOBILITY DECREASED 185 0.0026
638 ERYTHEMA MULTIFORME 24 0.0026
639 THROMBOSIS 207 0.0026
640 ERECTILE DYSFUNCTION 66 0.0026
641 WEIGHT DECREASED 717 0.0026
642 LIVER INJURY 63 0.0026
643 INFUSION RELATED REACTION 170 0.0026
644 JOINT STIFFNESS 67 0.0026
645 TOOTH ABSCESS 26 0.0026
646 FEMUR FRACTURE 79 0.0025
647 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
648 DIALYSIS 36 0.0025
649 CONDITION AGGRAVATED 771 0.0025
650 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 59 0.0025
651 UPPER RESPIRATORY TRACT INFECTION 116 0.0025
652 LUNG INFECTION 39 0.0025
653 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
654 HYPOTONIA 25 0.0025
655 TENDERNESS 26 0.0025
656 EYELID OEDEMA 29 0.0025
657 RENAL DISORDER 116 0.0025
658 NIGHT SWEATS 80 0.0025
659 PRESCRIBED OVERDOSE 48 0.0025
660 DEEP VEIN THROMBOSIS 161 0.0025
661 VOMITING 1164 0.0025
662 SPINAL PAIN 29 0.0025
663 ARTHRALGIA 1028 0.0025
664 FEBRILE NEUTROPENIA 164 0.0025
665 LIMB INJURY 67 0.0025
666 DYSSTASIA 72 0.0025
667 BACTERIAL INFECTION 46 0.0025
668 NEPHROPATHY 23 0.0025
669 CARDIO-RESPIRATORY ARREST 103 0.0025
670 INCONTINENCE 26 0.0025
671 COMA 117 0.0025
672 HYPOAESTHESIA ORAL 37 0.0025
673 MUSCLE ATROPHY 31 0.0024
674 COLD SWEAT 43 0.0024
675 VISUAL ACUITY REDUCED 81 0.0024
676 RESTLESSNESS 89 0.0024
677 SWELLING 227 0.0024
678 METASTASES TO LUNG 28 0.0024
679 SWELLING FACE 157 0.0024
680 UPPER LIMB FRACTURE 48 0.0024
681 LIVER FUNCTION TEST ABNORMAL 70 0.0024
682 LYMPHOPENIA 34 0.0024
683 CARDIOVASCULAR DISORDER 61 0.0024
684 COLITIS 91 0.0024
685 FAECES DISCOLOURED 52 0.0024
686 THROMBOCYTOPENIA 267 0.0024
687 NEURALGIA 58 0.0024
688 OESOPHAGITIS 26 0.0024
689 FEAR 64 0.0024
690 INTERVERTEBRAL DISC PROTRUSION 52 0.0024
691 ACTIVITIES OF DAILY LIVING IMPAIRED 47 0.0024
692 WHITE BLOOD CELL COUNT INCREASED 91 0.0024
693 BALANCE DISORDER 204 0.0024
694 LOCALISED INFECTION 57 0.0024
695 MYOCLONUS 28 0.0023
696 FLANK PAIN 22 0.0023
697 ROTATOR CUFF SYNDROME 30 0.0023
698 ABDOMINAL PAIN LOWER 59 0.0023
699 DRUG-INDUCED LIVER INJURY 73 0.0023
700 SPINAL DISORDER 22 0.0023
701 POISONING DELIBERATE 22 0.0023
702 RESPIRATORY DISTRESS 64 0.0023
703 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 127 0.0023
704 PANIC ATTACK 84 0.0023
705 WEIGHT INCREASED 513 0.0023
706 CHRONIC KIDNEY DISEASE 174 0.0023
707 BLOOD GLUCOSE FLUCTUATION 25 0.0023
708 GAIT DISTURBANCE 435 0.0023
709 THYROID DISORDER 35 0.0023
710 INTRAOCULAR PRESSURE INCREASED 29 0.0023
711 HEAD DISCOMFORT 40 0.0023
712 LEUKOPENIA 113 0.0023
713 PRESCRIBED UNDERDOSE 45 0.0023
714 PSORIASIS 294 0.0022
715 GASTROINTESTINAL HAEMORRHAGE 188 0.0022
716 FATIGUE 1751 0.0022
717 SECRETION DISCHARGE 28 0.0022
718 RESPIRATORY FAILURE 163 0.0022
719 THROAT IRRITATION 100 0.0022
720 ABASIA 55 0.0022
721 OXYGEN SATURATION DECREASED 125 0.0022
722 STATUS EPILEPTICUS 25 0.0022
723 ILL-DEFINED DISORDER 134 0.0022
724 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 115 0.0022
725 CONTUSION 212 0.0022
726 WEIGHT FLUCTUATION 23 0.0022
727 ACUTE HEPATIC FAILURE 30 0.0022
728 KIDNEY INFECTION 43 0.0022
729 ACCIDENT 26 0.0022
730 CYST 27 0.0022
731 ILEUS 27 0.0022
732 SCAR 37 0.0022
733 DIARRHOEA 1389 0.0021
734 HYPOPHAGIA 55 0.0021
735 ROAD TRAFFIC ACCIDENT 90 0.0021
736 MUSCULOSKELETAL DISCOMFORT 37 0.0021
737 SOMNOLENCE 432 0.0021
738 BLOOD GLUCOSE INCREASED 404 0.0021
739 PNEUMOTHORAX 34 0.0021
740 PRODUCT PRESCRIBING ERROR 51 0.0021
741 HAEMATEMESIS 54 0.0021
742 PHOTOSENSITIVITY REACTION 35 0.0021
743 BLISTER 119 0.0021
744 DEPRESSION 481 0.0021
745 BLOOD BILIRUBIN INCREASED 57 0.0021
746 JOINT INJURY 45 0.0021
747 NAUSEA 1666 0.0021
748 MUSCLE SPASMS 386 0.0021
749 LEUKOCYTOSIS 38 0.0021
750 OSTEOMYELITIS 38 0.0021
751 BURNING SENSATION 147 0.0021
752 DECREASED APPETITE 485 0.0021
753 DEMENTIA 58 0.0021
754 HYPOTHERMIA 21 0.0021
755 CARDIAC DISORDER 192 0.0021
756 ALOPECIA 403 0.0021
757 NEPHROLITHIASIS 94 0.0020
758 FEELING ABNORMAL 491 0.0020
759 RASH PRURITIC 111 0.0020
760 INITIAL INSOMNIA 21 0.0020
761 MUSCLE TIGHTNESS 33 0.0020
762 COLITIS ULCERATIVE 91 0.0020
763 URINARY TRACT INFECTION 347 0.0020
764 PAIN 1249 0.0020
765 BIPOLAR DISORDER 22 0.0020
766 NEUROLEPTIC MALIGNANT SYNDROME 24 0.0020
767 EPISTAXIS 151 0.0020
768 GALLBLADDER DISORDER 36 0.0020
769 LOCAL SWELLING 35 0.0020
770 CARPAL TUNNEL SYNDROME 28 0.0020
771 ENCEPHALOPATHY 49 0.0020
772 FLATULENCE 113 0.0020
773 ECONOMIC PROBLEM 30 0.0020
774 PRODUCT ADMINISTRATION ERROR 40 0.0020
775 POST PROCEDURAL COMPLICATION 38 0.0020
776 PANCREATITIS 104 0.0020
777 DYSGEUSIA 145 0.0019
778 HEPATIC ENZYME INCREASED 133 0.0019
779 DISCOMFORT 119 0.0019
780 DEAFNESS 51 0.0019
781 PALLOR 53 0.0019
782 PERICARDIAL EFFUSION 45 0.0019
783 COLON CANCER 29 0.0019
784 PRODUCT SUBSTITUTION ISSUE 112 0.0019
785 PHARYNGITIS 24 0.0019
786 ABDOMINAL PAIN 449 0.0019
787 BLOOD POTASSIUM DECREASED 58 0.0019
788 ACUTE RESPIRATORY FAILURE 37 0.0019
789 VISION BLURRED 264 0.0019
790 COVID-19 337 0.0019
791 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 49 0.0019
792 OSTEONECROSIS OF JAW 47 0.0019
793 FLUID RETENTION 96 0.0019
794 PROSTATIC SPECIFIC ANTIGEN INCREASED 26 0.0019
795 PNEUMONIA ASPIRATION 47 0.0019
796 IMMUNODEFICIENCY 28 0.0019
797 CHILLS 220 0.0019
798 PRURITUS 721 0.0019
799 ANKLE FRACTURE 29 0.0019
800 SEPSIS 208 0.0019
801 ACUTE MYELOID LEUKAEMIA 29 0.0019
802 FRACTURE 35 0.0018
803 CYANOSIS 29 0.0018
804 TREMOR 305 0.0018
805 RASH MACULAR 64 0.0018
806 DERMATITIS ALLERGIC 23 0.0018
807 PRODUCT USE IN UNAPPROVED INDICATION 451 0.0018
808 MATERNAL EXPOSURE DURING PREGNANCY 162 0.0018
809 DYSPHONIA 106 0.0018
810 MUSCULOSKELETAL CHEST PAIN 28 0.0018
811 NERVOUSNESS 94 0.0018
812 DEPRESSED MOOD 95 0.0018
813 ORAL PAIN 40 0.0018
814 CONSTIPATION 389 0.0018
815 ADVERSE DRUG REACTION 160 0.0018
816 SPEECH DISORDER 93 0.0018
817 MIDDLE INSOMNIA 33 0.0018
818 KNEE ARTHROPLASTY 37 0.0018
819 SPINAL FRACTURE 35 0.0017
820 NASAL CONGESTION 102 0.0017
821 PNEUMONITIS 47 0.0017
822 DRY SKIN 230 0.0017
823 DERMATITIS 36 0.0017
824 DRUG PRESCRIBING ERROR 33 0.0017
825 METASTASES TO BONE 28 0.0017
826 HALLUCINATION, VISUAL 36 0.0017
827 HIP ARTHROPLASTY 26 0.0017
828 LYMPHOCYTE COUNT DECREASED 30 0.0017
829 AGEUSIA 42 0.0017
830 CARDIAC ARREST 138 0.0017
831 PRURITUS GENERALISED 36 0.0017
832 STEVENS-JOHNSON SYNDROME 37 0.0017
833 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
834 HIP FRACTURE 53 0.0016
835 RASH 717 0.0016
836 BONE PAIN 96 0.0016
837 DRUG LEVEL INCREASED 27 0.0016
838 BLINDNESS UNILATERAL 23 0.0016
839 VIRAL INFECTION 54 0.0016
840 SENSORY DISTURBANCE 26 0.0016
841 DRUG TOXICITY 22 0.0016
842 MOUTH ULCERATION 34 0.0016
843 RESPIRATORY TRACT INFECTION 42 0.0016
844 MENTAL IMPAIRMENT 39 0.0016
845 PLATELET COUNT DECREASED 170 0.0016
846 PERITONITIS 33 0.0016
847 CHOKING 31 0.0016
848 OROPHARYNGEAL PAIN 147 0.0016
849 FOOT FRACTURE 30 0.0016
850 URTICARIA 265 0.0016
851 OSTEOPENIA 24 0.0016
852 INCORRECT PRODUCT ADMINISTRATION DURATION 34 0.0016
853 HYPERSENSITIVITY 291 0.0016
854 MUCOSAL INFLAMMATION 41 0.0016
855 MOVEMENT DISORDER 50 0.0016
856 CONVULSION 89 0.0016
857 EYE DISORDER 51 0.0015
858 ORAL HERPES 30 0.0015
859 EXTRAPYRAMIDAL DISORDER 38 0.0015
860 MYELODYSPLASTIC SYNDROME 22 0.0015
861 OFF LABEL USE 1330 0.0015
862 FEELING HOT 93 0.0015
863 DRUG DOSE OMISSION 248 0.0015
864 EYE PAIN 84 0.0015
865 WRONG TECHNIQUE IN DRUG USAGE PROCESS 54 0.0015
866 ANHEDONIA 39 0.0015
867 HEPATOTOXICITY 33 0.0015
868 SEDATION 38 0.0014
869 ABNORMAL DREAMS 40 0.0014
870 THROAT TIGHTNESS 39 0.0014
871 TOOTH DISORDER 32 0.0014
872 TREATMENT FAILURE 119 0.0014
873 PRODUCT USE ISSUE 269 0.0014
874 HYPERSOMNIA 41 0.0014
875 BREAST CANCER 133 0.0014
876 BLOOD GLUCOSE DECREASED 68 0.0014
877 RESPIRATORY ARREST 39 0.0014
878 RENAL INJURY 42 0.0014
879 DRUG EXPOSURE DURING PREGNANCY 48 0.0014
880 MENTAL DISORDER 61 0.0014
881 FEELING COLD 39 0.0014
882 POOR QUALITY SLEEP 30 0.0014
883 RASH GENERALISED 36 0.0014
884 FLUSHING 141 0.0014
885 SKIN DISORDER 46 0.0014
886 NEUROPATHY PERIPHERAL 131 0.0014
887 AGITATION 101 0.0014
888 NEEDLE ISSUE 40 0.0014
889 HAEMORRHAGE 143 0.0014
890 ERYTHEMA 280 0.0014
891 RETCHING 29 0.0014
892 HERNIA 26 0.0013
893 DIABETIC KETOACIDOSIS 32 0.0013
894 FEELING JITTERY 25 0.0013
895 NEUTROPENIA 178 0.0013
896 HERPES ZOSTER 75 0.0013
897 LETHARGY 75 0.0013
898 STAPHYLOCOCCAL INFECTION 43 0.0013
899 HOT FLUSH 98 0.0013
900 EYE SWELLING 48 0.0013
901 RASH ERYTHEMATOUS 61 0.0013
902 LYMPHADENOPATHY 45 0.0013
903 TOOTHACHE 23 0.0013
904 DISABILITY 25 0.0013
905 PHARMACEUTICAL PRODUCT COMPLAINT 32 0.0012
906 DRUG INEFFECTIVE 1623 0.0012
907 NEUTROPHIL COUNT DECREASED 50 0.0012
908 INFECTION 177 0.0012
909 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 220 0.0012
910 SKIN CANCER 26 0.0012
911 PREMATURE BABY 36 0.0012
912 SUICIDE ATTEMPT 72 0.0012
913 LABORATORY TEST ABNORMAL 35 0.0012
914 PAIN IN JAW 33 0.0012
915 INJECTION SITE REACTION 78 0.0011
916 ANAPHYLACTIC REACTION 62 0.0011
917 ADVERSE EVENT 103 0.0011
918 OSTEONECROSIS 36 0.0011
919 OCULAR HYPERAEMIA 52 0.0011
920 HYPOACUSIS 47 0.0011
921 SKIN DISCOLOURATION 50 0.0011
922 INTESTINAL OBSTRUCTION 41 0.0011
923 MALIGNANT NEOPLASM PROGRESSION 111 0.0011
924 DRY EYE 54 0.0011
925 MENTAL STATUS CHANGES 30 0.0011
926 NERVOUS SYSTEM DISORDER 33 0.0011
927 THERAPEUTIC RESPONSE SHORTENED 35 0.0011
928 EAR INFECTION 28 0.0011
929 OVERDOSE 223 0.0010
930 UNEVALUABLE EVENT 78 0.0010
931 BODY TEMPERATURE INCREASED 21 0.0010
932 INTENTIONAL OVERDOSE 66 0.0010
933 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
934 BREAST CANCER FEMALE 27 0.0010
935 DRUG ADMINISTRATION ERROR 31 0.0010
936 WHITE BLOOD CELL COUNT DECREASED 107 0.0010
937 AGGRESSION 49 0.0010
938 WITHDRAWAL SYNDROME 41 0.0010
939 FUNGAL INFECTION 32 0.0010
940 NEOPLASM MALIGNANT 62 0.0009
941 ABNORMAL BEHAVIOUR 36 0.0009
942 THERAPEUTIC RESPONSE DECREASED 55 0.0009
943 EMOTIONAL DISORDER 27 0.0009
944 SUICIDAL IDEATION 80 0.0009
945 DRUG EFFECT DECREASED 47 0.0009
946 NEOPLASM PROGRESSION 30 0.0009
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 61 0.0009
948 TREATMENT NONCOMPLIANCE 46 0.0008
949 UNDERDOSE 61 0.0008
950 ANGER 28 0.0008
951 TOXICITY TO VARIOUS AGENTS 138 0.0008
952 DYSKINESIA 33 0.0008
953 MOOD ALTERED 22 0.0008
954 EXPOSURE DURING PREGNANCY 50 0.0008
955 INCORRECT DOSE ADMINISTERED 183 0.0008
956 THERAPY NON-RESPONDER 36 0.0008
957 EYE IRRITATION 46 0.0008
958 DISEASE PROGRESSION 94 0.0008
959 PROCEDURAL PAIN 22 0.0008
960 FOETAL EXPOSURE DURING PREGNANCY 64 0.0008
961 IRRITABILITY 47 0.0008
962 DISEASE RECURRENCE 36 0.0008
963 INJECTION SITE MASS 27 0.0007
964 ACNE 55 0.0007
965 MOOD SWINGS 23 0.0007
966 CRYING 26 0.0007
967 GYNAECOMASTIA 22 0.0007
968 PROSTATE CANCER 55 0.0007
969 PRODUCT QUALITY ISSUE 88 0.0006
970 DRUG ABUSE 53 0.0006
971 LUNG NEOPLASM MALIGNANT 26 0.0006
972 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
973 DEATH 478 0.0006
974 EMOTIONAL DISTRESS 67 0.0006
975 SEIZURE 60 0.0005
976 SURGERY 30 0.0005
977 ILLNESS 52 0.0005
978 THERAPY CESSATION 25 0.0005
979 HOSPITALISATION 70 0.0005
980 INJECTION SITE BRUISING 36 0.0005
981 INJECTION SITE ERYTHEMA 55 0.0004
982 INJECTION SITE PRURITUS 29 0.0004
983 SKIN BURNING SENSATION 31 0.0004
984 MULTIPLE SCLEROSIS RELAPSE 29 0.0004
985 INJECTION SITE HAEMORRHAGE 33 0.0004
986 INJECTION SITE PAIN 125 0.0004
987 PRODUCT DOSE OMISSION ISSUE 108 0.0004
988 INJECTION SITE SWELLING 25 0.0003
989 THERAPY INTERRUPTED 22 0.0003
990 COMPLETED SUICIDE 25 0.0003
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 59 0.0003
992 DRUG WITHDRAWAL SYNDROME 24 0.0003
993 DRUG DEPENDENCE 33 0.0002
994 NO ADVERSE EVENT 27 0.0001